CLINICAL_TRIALS
trial_result
· 2014-09-09
Clinical Trial Update: Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
Summary
Post-marketing surveillance update summarizing safety observations for Atrovent in chronic obstructive pulmonary disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED